关注
Bhumika Patel
Bhumika Patel
Assistant Professor, Institute of Pharmacy, Nirma University, Ahmedabad
在 nirmauni.ac.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update
PG Jain, BD Patel
European Journal of Medicinal Chemistry 165, 198-215, 2019
1222019
Recent approaches to medicinal chemistry and therapeutic potential of dipeptidyl peptidase-4 (DPP-4) inhibitors
BD Patel, MD Ghate
European journal of medicinal chemistry 74, 574-605, 2014
1132014
Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway
K Shah, S Panchal, B Patel
Pharmacological Research 167, 105532, 2021
772021
Design, synthesis and anti-HIV activity of novel quinoxaline derivatives
SB Patel, BD Patel, C Pannecouque, HG Bhatt
European journal of medicinal chemistry 117, 230-240, 2016
642016
Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors
BD Patel, SV Bhadada, MD Ghate
Bioorganic Chemistry 72, 345-358, 2017
602017
An overview: application of Raman spectroscopy in pharmaceutical field
B D Patel, P J Mehta
Current Pharmaceutical Analysis 6 (2), 131-141, 2010
392010
Recent updates on Wnt signaling modulators: a patent review (2014-2020)
V Goswami, B Patel
Expert Opinion on Therapeutic Patents 31 (11), 1009-1043, 2021
212021
3D-QSAR studies on 5-hydroxy-6-oxo-1, 6-dihydropyrimidine-4-carboxamide derivatives as HIV-1 integrase inhibitors
S Patel, B Patel, H Bhatt
Journal of the Taiwan Institute of Chemical Engineers 59, 61-68, 2016
202016
Microwave‐Assisted Organic Synthesis: An Alternative Synthetic Strategy
JK Savjani, KT Savjani, BS Patel, AK Gajjar
ChemInform 42 (17), no, 2011
202011
Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities
R Maiti, B Patel, N Patel, M Patel, A Patel, N Dhanesha
Archives of Pharmacal Research, 1-28, 2023
192023
3D-QSAR studies of dipeptidyl peptidase-4 inhibitors using various alignment methods
BD Patel, MD Ghate
Medicinal Chemistry Research 3 (24), 1060-1069, 2015
192015
Predictive 3D-QSAR and HQSAR model generation of isocitrate lyase (ICL) inhibitors by various alignment methods combined with docking study
N Gupta, VK Vyas, B Patel, M Ghate
Medicinal Chemistry Research 6 (23), 2757-2768, 2014
132014
Computational studies on structurally diverse dipeptidyl peptidase IV inhibitors: an approach for new antidiabetic drug development
B Patel, M Ghate
Medicinal Chemistry Research 9 (22), 4505-4521, 2013
112013
CoMFA, CoMSIA, molecular docking and MOLCAD studies of pyrimidinone derivatives to design novel and selective tankyrase inhibitors
B Patel, A Patel, A Patel, H Bhatt
Journal of Molecular Structure 1221, 2020
92020
Structural Insights on 2-phenylquinazolin-4-one Derivatives as Tankyrase Inhibitors through CoMFA, CoMSIA, Topomer CoMFA and HQSAR Studies
A Patel, H Bhatt, B Patel
Journal of Molecular Structure 1249, 131636, 2022
82022
Pharmacophore mapping based virtual screening, molecular docking and ADMET studies of ROCK II inhibitors
S Shah, B Patel, J Savjani
Multiple Sclerosis and Related Disorders 21, 35-41, 2018
72018
A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2
U Chaube, BD Patel, HG Bhatt
3 Biotech 13 (1), 1-19, 2023
42023
Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer
U Chaube, R Dey, S Shaw, BD Patel, HG Bhatt
Future Medicinal Chemistry 14 (23), 1789-1809, 2022
42022
Piperine: Medicinal, Analytical and Therapeutics perspective
M Patel, D Patel, U Shah, A Patel, N Solanki, S Patel, S Patel, B Patel
Current Bioactive Compounds 18 (1), 2021
42021
Pharmacophore Mapping, Virtual Screening and Molecular Docking Studies of DPP-IV Inhibitors
MD Ghate, A Baksariya, N Gupta, BD Patel
4*
系统目前无法执行此操作,请稍后再试。
文章 1–20